ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
非小细胞肺癌患者接受帕博利珠单抗治疗后ctDNA反应：II期适应性试验结果
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-023-02598-9
Anagnostou, Valsamo; Ho, Cheryl; Nicholas, Garth; Juergens, Rosalyn Anne; Sacher, Adrian; Fung, Andrea S; Wheatley-Price, Paul; Laurie, Scott A; Levy, Benjamin; Brahmer, Julie R; Balan, Archana; Niknafs, Noushin; Avrutin, Egor; Zhu, Liting; Sausen, Mark; Bradbury, Penelope A; O'Donnell-Tormey, Jill; Gaudreau, Pierre Olivier; Ding, Keyue; Dancey, Janet
